Currently, cathepsin D, estrogen receptors, ErbB2, integrins, p53, urokinase plasminogen activator (uPA), uPA inhibitor-1 and urokinase receptor (uPAR) have been validated as biological prognostic markers in breast cancer [4]. This evidence concerns the gene ESR1 and breast cancer.